| | |
Hyderabad based Zenotech Labs has cloned Genetech's blockbuster, Rituxan.
Researchers at Hyderabad based Zenotech Labs have cloned a billion dollar blockbuster Rituxan, a Genentech product for Non-Hodgkins lymphoma, a deadly form of blood cancer.
That's is not all, the company is already in discussions with an European drug giant to licence out the product.
Going by the quality of researchers at Zenotech and the research product in the pipeline of Zenotech Labs, it could be the beginning of a strong future. But what really counts are the tedious regulatory processes involved in the regulatory approvals for biotech drugs.
ADS BY GOOGLE
video of the day
Barring IT & pharma, Q2 earnings to disappoint: Dimensions